IRIS
TRIESTE, LEOPOLDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.322
EU - Europa 4.788
AS - Asia 3.354
SA - Sud America 776
AF - Africa 81
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 20
Totale 15.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.060
IT - Italia 1.390
SG - Singapore 1.379
RU - Federazione Russa 1.187
CN - Cina 788
GB - Regno Unito 668
BR - Brasile 626
VN - Vietnam 437
DE - Germania 415
UA - Ucraina 282
CA - Canada 198
KR - Corea 161
HK - Hong Kong 157
DK - Danimarca 147
SE - Svezia 100
FR - Francia 91
IN - India 90
FI - Finlandia 83
NL - Olanda 81
IE - Irlanda 68
PL - Polonia 61
AR - Argentina 59
ES - Italia 51
TR - Turchia 50
JP - Giappone 46
MX - Messico 44
ZA - Sudafrica 38
BD - Bangladesh 35
BE - Belgio 34
EC - Ecuador 34
AT - Austria 28
ID - Indonesia 28
AU - Australia 27
PH - Filippine 23
IQ - Iraq 22
EU - Europa 20
IL - Israele 19
PK - Pakistan 19
PT - Portogallo 18
TW - Taiwan 18
CO - Colombia 16
MY - Malesia 16
RO - Romania 14
CH - Svizzera 13
LT - Lituania 13
PY - Paraguay 12
PE - Perù 10
MA - Marocco 9
JO - Giordania 8
SA - Arabia Saudita 8
CL - Cile 7
KE - Kenya 6
TN - Tunisia 6
UZ - Uzbekistan 6
VE - Venezuela 6
AZ - Azerbaigian 5
CY - Cipro 5
IR - Iran 5
LU - Lussemburgo 5
SN - Senegal 5
AL - Albania 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
GR - Grecia 4
JM - Giamaica 4
KZ - Kazakistan 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DM - Dominica 3
EG - Egitto 3
HN - Honduras 3
OM - Oman 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DZ - Algeria 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
UG - Uganda 2
UY - Uruguay 2
BB - Barbados 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
Totale 15.356
Salva come PNG Salva come JPEG
Città #
Dallas 1.846
Singapore 812
Beijing 385
Ashburn 376
Chandler 375
Woodbridge 342
Southend 341
Houston 267
Pisa 214
Moscow 185
San Mateo 175
Ann Arbor 170
Hong Kong 148
Jacksonville 142
Fairfield 123
Los Angeles 121
Ho Chi Minh City 115
Dearborn 105
Daejeon 97
Seattle 97
Cambridge 90
New York 89
Wilmington 89
Rome 88
Boardman 87
Falls Church 87
Milan 79
Hefei 77
São Paulo 72
The Dalles 71
Beauharnois 70
Hanoi 66
Dong Ket 65
Seoul 62
Dublin 61
Stevenage 61
Portsmouth 59
Lawrence 55
Warsaw 54
Fremont 49
Brooklyn 47
Santa Clara 46
Denver 43
Florence 41
Munich 41
Buffalo 39
Stockholm 38
London 37
Salerno 37
Montreal 34
Tokyo 33
Serra 31
Bologna 30
Poplar 30
Atlanta 29
Johannesburg 29
Buti 25
Montréal 25
Chennai 23
Helsinki 23
Redwood City 23
Paris 22
Phoenix 22
Ankara 21
Old Bridge 21
Chicago 20
Boston 19
Orem 19
Ottawa 19
Lucca 18
Nuremberg 18
Haiphong 17
Rio de Janeiro 16
Genoa 15
Livorno 15
Mexico City 15
Mumbai 15
Toronto 15
Trento 15
Frankfurt am Main 14
Hamburg 14
Istanbul 14
Tel Aviv 14
Da Nang 13
Querétaro 13
San Francisco 13
Vienna 13
Quito 12
Taipei 12
Turku 12
Xi'an 12
Brussels 11
Guayaquil 11
Charlotte 10
Isleworth 10
Melbourne 10
Philadelphia 10
Porto Alegre 10
Torino 10
Dhaka 9
Totale 9.140
Salva come PNG Salva come JPEG
Nome #
Nutri-Score and Food Perception: Insights from an Italian Study 710
On Robots and Insurance 532
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 427
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 358
The Effect of using Serifs in Brand Names on Luxury Perception 337
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 321
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 302
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 287
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 280
A systematic literature review of the economic impact of ankylosing spondylitis 267
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 265
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 253
Is EEG Suitable for Marketing Research? A Systematic Review 251
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 248
Natural and man-made disasters: challenges and international perspectives for insurance 247
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 240
Assessing the value of the use of diagnostic technology: trade offs for GPs 238
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 237
How colour saturation accelerates purchase behaviour, and influences food choice: 236
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 234
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 233
Which indicators for measuring the daily physical activity? An overview on the challenges and technology limits for Telehealth applications 233
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 231
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 224
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 220
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 220
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 217
The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS) 215
Health information technologies in systemic lupus erythematosus: focus on patient assessment 212
Asessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo: Preliminary Data 208
Columbus' egg and the engineer's effect in forecasting solutions adoption 206
Raiders of Lost Value 205
Systemic vasculitis: how little we know about their societal and economic burden 203
Management and Treatment of Type 1 And 2 Diabetes: State of Art 203
Conseguenze cliniche ed economiche dello switch ai biosimilari dell’Infliximab nei pazienti reumatologici in Toscana 201
KNOWLEDGE, USE AND DESIDERATA ABOUT INFORMATION AND COMMUNICATION TECHNOLOGIES SYSTEMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS. PRELIMINARY RESULTS FROM THE INTEGRATE PILOT PROJECT 201
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 198
Consideration on the Accuracy of Watch for Physical Activity Tracker 197
The influence of parental Dietary Behaviors, food literacy and chronotype on Children’s eating habits and psychometric factors 196
P56 Early Health Technology Assessment to Guide Introduction of Novel Technology into the Market: The Vostars System Case Study 189
The definition of a new organizational, technology-based, integrated home care model 187
Taste Your Consumer Audience. How Sensory Expertise Influences Food Choice 184
The economic impact of gout: a systematic literature review 184
Food literacy and food purchase behaviour 184
The cost of illness of ultra-rare Cryopyrin Associated Periodic Syndromes (CAPS) in Italy: Preliminary results from the Radicea project 183
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey 182
Razionale e strumenti della valutazione economica in sanità 177
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 170
Switching from infliximab‐originator to infliximab‐biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 166
Natura e ruolo degli indicatori nella logistica farmaceutica 161
Telemonitoring in Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years 156
Innovazione tecnologica, dinamica del contesto economico e logistica in sanità 155
Farmaci per le patologie autoimmuni. Traiettorie di trattamento nell’artrite reumatoide 154
L’evoluzione della distribuzione del farmaco e dell'erogazione dei servizi in farmacia 149
Finanziamenti pubblici 148
The nature, causes, and effects of skepticism on technology diffusion 145
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 145
Le start up 144
Cost analysis of technological vs. conventional upper limb rehabilitation for patients with neurological disorders: an Italian real-world data case study 143
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients’ care pathway 140
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 140
Strumenti per favorire gli investimenti e la competitività delle imprese 138
Valutazione dei risultati di una gara 130
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4) 128
EYE ON PACK. Visual search strategies in food choice 119
Analysis and Synthesis in Information Processing and Knowledge Creation 117
Propedeutica alle scienze Sperimentali. Introduzione al metodo scientifico e all'inferenza statistica. 116
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 116
The organizational dimension in rare and complex diseases care management: an application of RarERN Path© methodology in ataxias, dystonia and phenylketonuria 114
Valutazione dell’attività di malattia nei periodi di interruzione del trattamento con farmaci biologici modificanti la malattia reumatica in pazienti con artrite reumatoide 110
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 107
State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases 106
Industria 4.0 e Digitalizzazione 102
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 81
null 63
Validazione degli algoritmi di selezione dei pazienti reumatologici nei database amministrativi toscani e traiettorie di aderenza ai farmaci biologici modificanti la malattia nell’artrite reumatoide 44
null 13
Totale 15.483
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.620
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021713 0 0 0 0 0 116 75 67 86 72 133 164
2021/2022745 23 141 29 50 9 15 96 159 56 70 31 66
2022/2023841 65 85 46 134 100 136 10 47 122 28 36 32
2023/2024465 43 18 61 22 18 62 51 38 7 26 29 90
2024/20253.729 66 86 245 184 272 264 565 871 307 171 467 231
2025/20265.974 504 1.192 1.623 1.203 1.001 451 0 0 0 0 0 0
Totale 15.483